Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-24 @ 12:00 PM
NCT ID:
NCT07225361
Brief Title:
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Official Title:
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Study:
NCT07225361
Protocol Section:
NCT07225361